{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:39:52Z","timestamp":1787510392892,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["1U01IP001160)"],"award-info":[{"award-number":["1U01IP001160)"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","award":["GAT.1890-01665909-SUB"],"award-info":[{"award-number":["GAT.1890-01665909-SUB"]}],"id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Data on the economic burden of RSV-associated illness will inform decisions on the programmatic implementation of maternal vaccines and monoclonal antibodies. We estimated the cost of RSV-associated illness in fine age bands to allow more accurate cost-effectiveness models to account for a limited duration of protection conferred by short- or long-acting interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a costing study at sentinel sites across South Africa to estimate out-of-pocket and indirect costs for RSV-associated mild and severe illness. We collected facility-specific costs for staffing, equipment, services, diagnostic tests, and treatment. Using case-based data we calculated a patient day equivalent (PDE) for RSV-associated hospitalizations or clinic visits; the PDE was multiplied by the number of days of care to provide a case cost to the healthcare system. We estimated the costs in 3-month age intervals in children aged\u2009&lt;\u20091\u00a0year and as a single group for children aged 1\u20134\u00a0years. We then applied our data to a modified version of the World Health Organization tool for estimating the mean annual national cost burden, including medically and non-medically attended RSV-associated illness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The estimated mean annual cost of RSV-associated illness in children aged\u2009&lt;\u20095\u00a0years was US dollars ($)137,204,393, of which 76% ($111,742,713) were healthcare system incurred, 6% ($8,881,612) were out-of-pocket expenses and 13% ($28,225,.801) were indirect costs. Thirty-three percent ($45,652,677\/$137,204,393) of the total cost in children aged\u2009&lt;\u20095\u00a0years was in the\u2009&lt;\u20093-month age group, of which 52% ($71,654,002\/$137,204,393) were healthcare system incurred. The costs of non-medically attended cases increased with age from $3,307,218 in the\u2009&lt;\u20093-month age group to $8,603,377 in the 9\u201311-month age group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among children\u2009&lt;\u20095\u00a0years of age with RSV in South Africa, the highest cost burden was in the youngest infants; therefore, interventions against RSV targeting this age group are important to reduce the health and cost burden of RSV-associated illness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-023-02854-2","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T06:08:14Z","timestamp":1681366094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The economic burden of RSV-associated illness in children aged\u2009&lt;\u20095\u00a0years, South Africa 2011\u20132016"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8040-1717","authenticated-orcid":false,"given":"Jocelyn","family":"Moyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Tempia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibongile","family":"Walaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith L.","family":"McMorrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florette","family":"Treurnicht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"von Gottberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Variava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"issue":"10098","key":"2854_CR1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","volume":"390","author":"T Shi","year":"2017","unstructured":"Shi T, McAllister DA, O\u2019Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet (London, England). 2017;390(10098):946\u201358. https:\/\/doi.org\/10.1016\/S0140-6736(17)30938-8.","journal-title":"Lancet (London, England)"},{"key":"2854_CR2","doi-asserted-by":"publisher","unstructured":"Vekemans J, Moorthy V, Giersing B, et al. Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics. Vaccine. Published online January 25, 2018. https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.092.","DOI":"10.1016\/j.vaccine.2017.09.092"},{"key":"2854_CR3","doi-asserted-by":"publisher","unstructured":"Li X, Lander W, Antillon M, et al. Health and economic burden of respiratory syncytial virus (RSV) disease and the costeffectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries. BMC Med. 2020;18(1):82.18. https:\/\/doi.org\/10.1186\/s12916-020-01537-6.","DOI":"10.1186\/s12916-020-01537-6"},{"key":"2854_CR4","doi-asserted-by":"crossref","unstructured":"Moyes J, Tempia S, Walaza S. The burden of RSV-assocaited illness in children <5 years South Africa 2011-2016. BMC Med.\u00a0medRxiv. 2022:1\u201313.","DOI":"10.1101\/2022.06.20.22276680"},{"key":"2854_CR5","unstructured":"Consumer Price index tables. http:\/\/www.statssa.gov.za\/publications\/P0141\/CPIHistory.pdf. Accessed Apr 2023."},{"key":"2854_CR6","unstructured":"National Minimum Wage for South Africa. https:\/\/www.treasury.gov.za\/publications\/other\/nmw%20report%20draft%20cop%20final.pdf. Accessed 11 Apr 2018."},{"key":"2854_CR7","unstructured":"Consumer Price index 2018. http:\/\/www.statssa.gov.za\/publications\/P0211\/P02111stQuarter2018.pdf. Accessed Apr\u00a02018."},{"key":"2854_CR8","unstructured":"NHLS price list. ational Health Laboratory Service. State Price List. https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=2ahUKEwiOu6y7qOXeAhXlCsAKHaclC7cQFjAAegQICRAC&url=http%3A%2F%2Fwww.health.gov.za%2Findex.php%2Fshortcodes%2F2015-03-29-10-42-47%2F2015-04-30-09-10-23%2Funiform-patient-feeschedule%2Fcategory%2F221-u2014%3Fdownload%3D895%3Anhls-state-price-list-2013-annexurem&usg=AOvVaw1-pJVdlBG3sX8vf0DOk3F6. Accessed Nov\u00a02016"},{"key":"2854_CR9","unstructured":"www.health.gov.za\/index.php\/shortcodes\/2015-03-29-10-42-47\/2015-04-30-08-18-10\/2015-04-30-08-21-56%3Fdownload%3D2584:2015-national-antenatal-hiv-prevalence-survey-final-23oct17+&cd=1&hl=en&ct=clnk&gl=za. Accessed 17 May 2019."},{"key":"2854_CR10","unstructured":"WHO model for Estimating burden. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/250085\/WHO-IVB-16.04-eng.pdf;jsessionid=B456F1A72039C77EEF50C3BAD48069F3?sequence=1. Accessed Apr 2018."},{"key":"2854_CR11","unstructured":"The World Bank. The World Bank indicators. 2021. Published 2021. https:\/\/data.worldbank.org\/indicator\/NY.GDP.DEFL.KD.ZG?locations=ZAI. Accessed Dec 2021."},{"key":"2854_CR12","unstructured":"Statistics South Africa. South Africa. Mid-year population estimates 2015. 2015;P0302(July):20. https:\/\/www.statssa.gov.za\/publications\/P0302\/P03022015.pdf. Accessed Apr 2018."},{"key":"2854_CR13","unstructured":"Statistics SA. Life expectancy estimate, South Africa. http:\/\/www.statssa.gov.za\/?p=2973. Accessed Sept 2022."},{"issue":"5","key":"2854_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/irv.12650","volume":"13","author":"S Tempia","year":"2019","unstructured":"Tempia S, Moyes J, Cohen AL, et al. Health and economic burden of influenza-associated illness in South Africa, 2013\u20132015. Influenza Other Respi Viruses. 2019;13(5):484\u201395. https:\/\/doi.org\/10.1111\/irv.12650.","journal-title":"Influenza Other Respi Viruses"},{"issue":"1","key":"2854_CR15","doi-asserted-by":"publisher","first-page":"010408","DOI":"10.7189\/jogh.06.010408","volume":"6","author":"S Zhang","year":"2016","unstructured":"Zhang S, Sammon PM, King I, et al. Cost of management of severe pneumonia in young children: systematic analysis. J Glob Health. 2016;6(1):010408. https:\/\/doi.org\/10.7189\/jogh.06.010408.","journal-title":"J Glob Health."},{"key":"2854_CR16","doi-asserted-by":"publisher","unstructured":"Sinha A, Soyeon K, Ginsberg G, et al.\u00a0Economic burden of acute lower respiratory tract infection in South African children. Paediatr Int Child Health.\u00a02012;32(2):65\u201373.\u00a0https:\/\/doi.org\/10.1179\/2046905512Y.0000000010.","DOI":"10.1179\/2046905512Y.0000000010"},{"key":"2854_CR17","doi-asserted-by":"publisher","unstructured":"Stenberg K, Lauer JA, Gkountouras G, Fitzpatrick C, Stanciole A. Econometric estimation of WHO \u2011 CHOICE country \u2011 specific costs for inpatient and outpatient health service delivery. Cost Eff Resour Alloc. 1\u201315. https:\/\/doi.org\/10.1186\/s12962-018-0095-x.Published online 2018.","DOI":"10.1186\/s12962-018-0095-x."},{"key":"2854_CR18","unstructured":"South Africa Healthcare budget 2016. https:\/\/www.gov.za\/speeches\/debate-health-budget-vote-national-assembly-10-may-2016-dr-aaron-motsoaledi-minister-health. Accessed July 2021."},{"key":"2854_CR19","unstructured":"South African National Department of Health Strategic plans. https:\/\/www.health.gov.za\/wpcontent\/uploads\/2020\/11\/depthealthstrategicplanfinal2020-21to2024-25-1.pdf. Accessed Sept 2022."},{"issue":"10","key":"2854_CR20","doi-asserted-by":"publisher","first-page":"e1316","DOI":"10.1016\/S2214-109X(20)30251-5","volume":"8","author":"HJ Zar","year":"2020","unstructured":"Zar HJ, Nduru P, Stadler JAM, et al. Articles Early-life respiratory syncytial virus lower respiratory tract infection in a South African birth cohort\u202f: epidemiology and effect on lung health. Lancet Glob Heal. 2020;8(10):e1316\u201325. https:\/\/doi.org\/10.1016\/S2214-109X(20)30251-5.","journal-title":"Lancet Glob Heal"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02854-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-02854-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02854-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T06:11:45Z","timestamp":1681366305000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-02854-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2854"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-02854-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.06.20.22276632","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"23 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SARI and SRI protocol was approved by the University of the Witwatersrand Human Research Ethics Committee (HREC) and the University of KwaZulu-Natal Human Biomedical Research Ethics Committee (BREC) protocol numbers M081042 and BF157\/08 respectively. The ILI protocol was approved by HREC and BREC protocol numbers M120133 and BF080\/12. respectively. The healthcare utilization survey was approved by HREC M120367 and BREC BE209\/13. This surveillance was deemed non-research by the US Centers for Disease Control and Prevention (non-research determination number: 2012\u20136197). All participants signed written informed consent prior to enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors report no conflict of interest, other than the source of funding noted above.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}